FDA Approves First Fast-Acting Oral Drug for Clinical Depression That Works in 1 Week
The drug, Auvelity, from Axsome Therapeutics claims to start working within one week.
A new medication called Auvelity was just FDA-approved to treat major depressive disorder , also known as clinical depression, in as little as one week. The new “fast-acting” oral drug for clinical depression, from Axsome Therapeutics, could change the way we treat mental health.by the FDA. Auvelity is an N-methyl D-aspartate receptor antagonist, marking the first new type of medication to be approved for clinical depression in 60 years.
In short, most antidepressant drugs work on the same neurotransmitters like dopamine and serotonin, but Auvelity focuses on glutamate receptors instead,
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Vehicle-To-Grid Trials Taking Place In Massachusetts & New YorkVehicle to grid trial programs are happening in more places like Massachusetts, Brooklyn, and Florida as utilities get on board.
Read more »
Commentary: Benefits of Inflation Reduction Act far-rangingThe Inflation Reduction Act, or IRA, will lower prescription drug, health care, and...
Read more »
Latest Covid Boosters Are Set to Roll Out Before Human Testing Is CompletedThe FDA is expected to authorize modified versions of Covid-19 vaccines. The U.S. wants to roll them out before it’s too cold—but that’s before data comes in from human trials
Read more »